1256 related articles for article (PubMed ID: 12730770)
1. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
Seeman E
Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
[TBL] [Abstract][Full Text] [Related]
2. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
3. Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women.
Szulc P; Seeman E; Duboeuf F; Sornay-Rendu E; Delmas PD
J Bone Miner Res; 2006 Dec; 21(12):1856-63. PubMed ID: 17002580
[TBL] [Abstract][Full Text] [Related]
4. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
Seeman E
Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
[TBL] [Abstract][Full Text] [Related]
5. The structural and biomechanical basis of the gain and loss of bone strength in women and men.
Seeman E
Endocrinol Metab Clin North Am; 2003 Mar; 32(1):25-38. PubMed ID: 12699291
[TBL] [Abstract][Full Text] [Related]
6. Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss.
Duan Y; Turner CH; Kim BT; Seeman E
J Bone Miner Res; 2001 Dec; 16(12):2267-75. PubMed ID: 11760841
[TBL] [Abstract][Full Text] [Related]
7. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
Riggs BL; Parfitt AM
J Bone Miner Res; 2005 Feb; 20(2):177-84. PubMed ID: 15647810
[TBL] [Abstract][Full Text] [Related]
8. A stochastic analysis of iliac trabecular bone dynamics.
Reeve J
Clin Orthop Relat Res; 1986 Dec; (213):264-78. PubMed ID: 3780102
[TBL] [Abstract][Full Text] [Related]
9. Invited Review: Pathogenesis of osteoporosis.
Seeman E
J Appl Physiol (1985); 2003 Nov; 95(5):2142-51. PubMed ID: 14555675
[TBL] [Abstract][Full Text] [Related]
10. A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage.
Nyman JS; Yeh OC; Hazelwood SJ; Martin RB
Bone; 2004 Jul; 35(1):296-305. PubMed ID: 15207770
[TBL] [Abstract][Full Text] [Related]
11. [Rational bases for the treatment of osteoporosis].
Adami S; Bianchini D; Zanfisi C; Fracassi E; Galvanini G
Ann Ital Med Int; 1995 Oct; 10 Suppl():18S-21S. PubMed ID: 8562260
[TBL] [Abstract][Full Text] [Related]
12. Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging.
Duan Y; Beck TJ; Wang XF; Seeman E
J Bone Miner Res; 2003 Oct; 18(10):1766-74. PubMed ID: 14584886
[TBL] [Abstract][Full Text] [Related]
13. Thinking inside and outside the envelopes of bone: dedicated to PDD.
Szulc P; Seeman E
Osteoporos Int; 2009 Aug; 20(8):1281-8. PubMed ID: 19590836
[TBL] [Abstract][Full Text] [Related]
14. Age- and menopause-related bone loss compromise cortical and trabecular microstructure.
Seeman E
J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1218-25. PubMed ID: 23833200
[TBL] [Abstract][Full Text] [Related]
15. Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism.
Yajima A; Inaba M; Tominaga Y; Ito A
Am J Kidney Dis; 2007 Mar; 49(3):440-51. PubMed ID: 17336706
[TBL] [Abstract][Full Text] [Related]
16. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
Steiniche T
APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
[TBL] [Abstract][Full Text] [Related]
17. Estrogen, androgen, and the pathogenesis of bone fragility in women and men.
Seeman E
Curr Osteoporos Rep; 2004 Sep; 2(3):90-6. PubMed ID: 16036088
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis. Efficacy and safety of a bisphosphonate dosed once weekly.
Baran D
Geriatrics; 2001 Mar; 56(3):28-32. PubMed ID: 11252758
[TBL] [Abstract][Full Text] [Related]
19. Primary hyperparathyroidism: lessons from bone histomorphometry.
Eriksen EF
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N95-7. PubMed ID: 12412784
[TBL] [Abstract][Full Text] [Related]
20. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
Boyce RW; Paddock CL; Franks AF; Jankowsky ML; Eriksen EF
J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
